Related Experiment Video
Updated: Oct 23, 2025

09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
11.6K
A proposal: How to study pro-myelinating proteins in MS.
1Department of Neurology, Medical College of Wisconsin, Medical College of Wisconsin, 8701 W Watertown Plank Rd, Milwaukee, WI 53226, United States of America.
Autoimmunity Reviews
|August 20, 2021
Summary
This study explores promoting repair in multiple sclerosis (MS) by monitoring myelin regeneration. Linking pro-myelinating proteins to imaging changes could enable new therapies for CNS repair.
Area of Science:
- Neuroscience
- Immunology
- Radiology
Background:
- Multiple sclerosis (MS) is a central nervous system (CNS) disease causing inflammation and degeneration.
- A key challenge in MS is promoting endogenous repair, specifically remyelination, to preserve neurons and prevent disease progression.
Purpose of the Study:
- To investigate methods for monitoring in vivo remyelination in MS patients.
- To link changes in pro-myelinating proteins with imaging markers of myelin repair.
Main Methods:
- Utilizing advanced MRI techniques like quantitative susceptibility mapping (QSM) and myelin water imaging (MWI).
- Monitoring MS lesions with gadolinium enhancement (Gd+) to capture the acute inflammatory phase and subsequent remyelination.
- Analyzing blood and cerebrospinal fluid (CSF) for pro-myelinating protein levels (e.g., N-CAM, BDNF).
Main Results:
- Evidence suggests histological repair and remyelination occur in MS patients.
- Non-conventional MRI techniques can detect changes associated with acute remyelination.
- The period following acute inflammation in MS lesions presents an optimal window for monitoring repair.
Conclusions:
- Monitoring pro-myelinating proteins alongside advanced MRI in MS lesions can reveal links between protein levels and myelin formation.
- This approach may pave the way for therapeutic strategies involving direct administration of proteins to promote CNS remyelination.

